![RCSB PDB - 4AN2: Crystal structures of human MEK1 with carboxamide-based allosteric inhibitor XL518 (GDC-0973), or related analogs. RCSB PDB - 4AN2: Crystal structures of human MEK1 with carboxamide-based allosteric inhibitor XL518 (GDC-0973), or related analogs.](https://cdn.rcsb.org/images/structures/4an2_model-1.jpeg)
RCSB PDB - 4AN2: Crystal structures of human MEK1 with carboxamide-based allosteric inhibitor XL518 (GDC-0973), or related analogs.
![Frontiers | Epstein-Barr Virus in Burkitt Lymphoma in Africa Reveals a Limited Set of Whole Genome and LMP-1 Sequence Patterns: Analysis of Archival Datasets and Field Samples From Uganda, Tanzania, and Kenya Frontiers | Epstein-Barr Virus in Burkitt Lymphoma in Africa Reveals a Limited Set of Whole Genome and LMP-1 Sequence Patterns: Analysis of Archival Datasets and Field Samples From Uganda, Tanzania, and Kenya](https://www.frontiersin.org/files/Articles/812224/fonc-12-812224-HTML-r1/image_m/fonc-12-812224-g002.jpg)
Frontiers | Epstein-Barr Virus in Burkitt Lymphoma in Africa Reveals a Limited Set of Whole Genome and LMP-1 Sequence Patterns: Analysis of Archival Datasets and Field Samples From Uganda, Tanzania, and Kenya
![Autophagy promotes escape from phosphatidylinositol 3‐kinase inhibition in estrogen receptor‐positive breast cancer - Yang - 2018 - The FASEB Journal - Wiley Online Library Autophagy promotes escape from phosphatidylinositol 3‐kinase inhibition in estrogen receptor‐positive breast cancer - Yang - 2018 - The FASEB Journal - Wiley Online Library](https://faseb.onlinelibrary.wiley.com/cms/asset/f3f38fe1-62ee-4aeb-9daa-195684feb70d/fsb2fj201700477r-fig-0002-m.jpg)
Autophagy promotes escape from phosphatidylinositol 3‐kinase inhibition in estrogen receptor‐positive breast cancer - Yang - 2018 - The FASEB Journal - Wiley Online Library
![The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer | eLife The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer | eLife](https://iiif.elifesciences.org/lax/15828%2Felife-15828-fig4-v3.tif/full/1500,/0/default.jpg)
The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer | eLife
![The Quest for Orally Available Selective Estrogen Receptor Degraders (SERDs) - Wang - 2020 - ChemMedChem - Wiley Online Library The Quest for Orally Available Selective Estrogen Receptor Degraders (SERDs) - Wang - 2020 - ChemMedChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/bdd34c08-ab19-4692-ab41-faa8ceae7fa1/cmdc202000473-toc-0001-m.png)
The Quest for Orally Available Selective Estrogen Receptor Degraders (SERDs) - Wang - 2020 - ChemMedChem - Wiley Online Library
![The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer | eLife The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer | eLife](https://iiif.elifesciences.org/lax/15828%2Felife-15828-fig4-figsupp3-v3.tif/full/,1500/0/default.jpg)
The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer | eLife
![Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines: Cell Systems Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines: Cell Systems](https://www.cell.com/cms/attachment/e55d239d-7c64-4735-8555-0024f2d1d0b4/fx1_lrg.jpg)
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines: Cell Systems
![The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer. - Abstract - Europe PMC The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4961458/bin/elife-15828-fig3.jpg)
The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer. - Abstract - Europe PMC
![God of War Ragnarok vs Elden Ring: la batalla sigue ahora en los GDC Awards 2023; aquí todos los nominados God of War Ragnarok vs Elden Ring: la batalla sigue ahora en los GDC Awards 2023; aquí todos los nominados](https://i.blogs.es/715510/god-of-war-ragnarok-vs-elden-ring-la-batalla-sigue-ahora-en-los-gdc-awards-2023/1366_2000.jpeg)
God of War Ragnarok vs Elden Ring: la batalla sigue ahora en los GDC Awards 2023; aquí todos los nominados
![The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer. - Abstract - Europe PMC The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4961458/bin/elife-15828-fig4-figsupp2.jpg)
The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer. - Abstract - Europe PMC
![The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer | eLife The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer | eLife](https://iiif.elifesciences.org/lax/15828%2Felife-15828-fig7-v3.tif/full/1500,/0/default.jpg)
The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer | eLife
![The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer | eLife The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer | eLife](https://iiif.elifesciences.org/lax/15828%2Felife-15828-fig1-v3.tif/full/,1500/0/default.jpg)
The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer | eLife
![The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer | eLife The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer | eLife](https://iiif.elifesciences.org/lax/15828%2Felife-15828-fig6-v3.tif/full/1500,/0/default.jpg)
The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer | eLife
![Nutrients | Free Full-Text | Liver Metastatic Breast Cancer: Epidemiology, Dietary Interventions, and Related Metabolism Nutrients | Free Full-Text | Liver Metastatic Breast Cancer: Epidemiology, Dietary Interventions, and Related Metabolism](https://www.mdpi.com/nutrients/nutrients-14-02376/article_deploy/html/images/nutrients-14-02376-g001.png)
Nutrients | Free Full-Text | Liver Metastatic Breast Cancer: Epidemiology, Dietary Interventions, and Related Metabolism
![Challenger – Unity 5 demo – The Blacksmith – 3D Art by Sergey Samuilov - zbrushtuts | Persian warrior, Character design, 3d model character Challenger – Unity 5 demo – The Blacksmith – 3D Art by Sergey Samuilov - zbrushtuts | Persian warrior, Character design, 3d model character](https://i.pinimg.com/originals/56/d0/e2/56d0e2525ecd589348e956eb5df3f6e9.jpg)
Challenger – Unity 5 demo – The Blacksmith – 3D Art by Sergey Samuilov - zbrushtuts | Persian warrior, Character design, 3d model character
![Novel Carboxamide-Based Allosteric MEK Inhibitors: Discovery and Optimization Efforts toward XL518 (GDC-0973) | ACS Medicinal Chemistry Letters Novel Carboxamide-Based Allosteric MEK Inhibitors: Discovery and Optimization Efforts toward XL518 (GDC-0973) | ACS Medicinal Chemistry Letters](https://pubs.acs.org/cms/10.1021/ml300049d/asset/images/large/ml-2012-00049d_0006.jpeg)
Novel Carboxamide-Based Allosteric MEK Inhibitors: Discovery and Optimization Efforts toward XL518 (GDC-0973) | ACS Medicinal Chemistry Letters
![Autophagy promotes escape from phosphatidylinositol 3‐kinase inhibition in estrogen receptor‐positive breast cancer - Yang - 2018 - The FASEB Journal - Wiley Online Library Autophagy promotes escape from phosphatidylinositol 3‐kinase inhibition in estrogen receptor‐positive breast cancer - Yang - 2018 - The FASEB Journal - Wiley Online Library](https://faseb.onlinelibrary.wiley.com/cms/asset/ac681cb0-2aec-4d77-b1cc-f5f958ad1bab/fsb2fj201700477r-fig-0005-m.jpg)